SV Health Investors β Full Portfolio
206 tracked investments Β· page 1 of 2 Β· listed companies and verified rows first
Bedford, US
Board seatCharles WardenΒ· per SEC Form D
Alector develops therapies targeting neurodegenerative diseases including Alzheimer's, frontotemporal dementia, and Parkinson's disease through protein removal, replacement, and immune cell restoration.
AI & Machine LearningBiotechHealthtechLongevityMedical DevicesSan Francisco, US
Arnon Rosenthal(Ph.D.)Carl Gordon(Director)Tillman Gerngross(Director)
BoardTerry McGuire(Director)
Enabling telemedicine and digital health
Biotech company that reached IPO
BiotechCambridge
KEVIN LEE(Executive Officer, Director)FELIX J. BAKER(Director)RICHARD N. KENDER(Director)GREGORY WINTER(Director)STEPHEN SANDS(Director)NIGEL CROCKETT(Executive Officer)
Xilio (Xilio Therapeutics) is a clinical-stage biotechnology company developing tumor-selective immunotherapies, including checkpoint inhibitors, T cell engagers and related molecules, for the treatment of cancer.
BiotechHealthtechWaltham, US
Paul Clancy(Director)Daniel Curran(Director)Nancy Hong(Director)Rachel Humphrey(Director)Daniel Lynch(Director)Michael Ross(Director)
Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals.
AI & Machine LearningBiotechDeep TechHealthtech
Jane Osbourn(Chief Executive Officer)
EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.
BiotechMedical Devices
Paul Yoo(Co-founder, President & Chief Scientific Officer)Sasha John(Co-founder and Chief Innovation Officer)Keith R Carlton(Chief Executive Officer)
Mestag Therapeutics is an immunology company developing first-in-class agonist antibody therapies for cancer and inflammatory diseases based on fibroblast biology, and operates a RAFT platform for discovering new drug targets.
AI & Machine LearningBiotechHealthtech
Susan Hill(Founder & Chief Executive Officer)Michael B. Brenner(Founder)Chris Buckley(Founder)Mark Coles(Founder)Soumya Raychaudhuri(Founder)David A. Tuveson(Founder)
Axon Therapies develops the SAVM procedure, an implant-free catheter-based ablation therapy that targets the right greater splanchnic nerve to reduce overactive sympathetic nerve activity in patients with heart failure with preserved ejection fraction (HFpEF).
HealthtechMedical DevicesNew York, US
Howard R. Levin(Executive Officer, Director)Mark Gelfand(Executive Officer)Mitchell S. Bloom(Executive Officer)
Board seatPaul LaVioletteΒ· per SEC Form D Β· $2M raise Β· filed Apr 2016
Marlborough, US
Bruce Robertson(Director)Lauren Jennings(Executive Officer)Christopher Kroeger(Director)Omar Amirana(Director)Warren Clark(Executive Officer)James Garvey(Director)
Board seatPaul LaVioletteΒ· per SEC Form D
BiotechTewksbury, US
George J. Fazio(Executive Officer, Director)Dan B. Curtis(Executive Officer)David S. Celermajer(Director)Uri Geiger(Director)Hemant Taneja(Director)
Board seatPaul LaVioletteΒ· per SEC Form D Β· $11.1M raise Β· filed Jun 2025
RejuvenAir, developed by CSA Medical, is a bronchoscopic cryosurgical device that sprays metered doses of liquid nitrogen to destroy damaged airway cells and treat the underlying cause of COPD with Chronic Bronchitis.
HealthtechMedical DevicesLutherville, US
Vincent Owens(Director)Ellen Sheets(Executive Officer, Director)Richard Kent(Director)Thomas Snead(Director)Ian J. Vawter(Executive Officer)
BoardTracy Marshbanks(Director)
Board seatPaul LaVioletteΒ· per SEC Form D
HealthtechSanta Rosa, US
Yuval Binur(Director)Dan Rose(Executive Officer)Gordon Bishop(Executive Officer, Director)George Fazio(Director)David Boyle(Executive Officer)Dan T. Lemaitre(Executive Officer, Director)
Board seatPaul LaVioletteΒ· per SEC Form D
Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery sensor and remote monitoring platform for managing NYHA class III heart failure.
Digital HealthHealthtechMedical DevicesWoodridge, US
Jonathan Jonas(Director)Harry Rowland(Executive Officer, Director)Raymond S. Barrett, Jr.(Director)Anthony I Nunez(Executive Officer, Director)Sam R. Leno(Director)Leslie A. Saxon(Director)
Board seatPaul LaVioletteΒ· per SEC Form D
HealthtechMinneapolis, US
Howard Levin(Director)Mark Christopherson(Executive Officer, Director)
BoardDavid Neustaedter(Director)Michael Hurley(Director)
Board seatPaul LaVioletteΒ· per SEC Form D
HealthtechSan Diego, US
John Buhler(Director)Rex Bright(Director)Martyn Gross(Executive Officer, Director)Kathy Scott(Executive Officer)David Hale(Director)
Board seatPaul LaVioletteΒ· per SEC Form D Β· $43M raise Β· filed Oct 2021
SpectraWave develops imaging and physiology technologies for coronary care, combining deep optical coherence tomography, near-infrared spectroscopy, and wire-free FFR measurements on a single platform to support percutaneous coronary intervention planning in catheterization laboratories.
AI & Machine LearningHealthtechMedical DevicesBedford, US
Eman Namati(Executive Officer, Director)Eric Swanson(Director)Martin Seifert(Executive Officer, Director)Steven Hochberg(Director)Guillermo Tearney(Director)
Board seatPaul LaVioletteΒ· per SEC Form D
BiotechPompano Beach, US
Virginia Sullivan(Executive Officer)Marc Loev(Director)Richard Chen Mao(Director)Gary Perryman(Director)Scott Sidwell(Executive Officer)Laura Tyler Perryman(Director)
Board seatPaul LaVioletteΒ· per SEC Form D Β· $8M raise Β· filed Sep 2020
Asensus Surgical (formerly TransEnterix) develops surgical robotics, advanced visualization, and instrumentation technology for surgeons.
HealthtechMedical DevicesRoboticsMorrisville, US
Anthony Fernando(Executive Officer)Paul A LaViolette(Director)Jane H Hsiao(Director)William N Kelley(Director)Andrea Biffi(Director)William, Jr. N Starling(Director)
Board seatPaul LaVioletteΒ· per SEC Form D
BiotechMaple Grove, US
MARY LINCOLN CAMPBELL(Director)MITCHELL DANN(Director)JON PATRICK ST. GERMAIN(Executive Officer)DAVID KRENN(Executive Officer)PAUL A. LAVIOLETTE(Director)JOHANN NEISZ(Executive Officer, Director)
Board seatPaul LaVioletteΒ· per SEC Form D
AdvanCell develops radioisotope-based therapies, using Th-228 sourced through the U.S.
BiotechHealthtechMedical DevicesCambridge, US
Philina Lee(Executive Officer, Director)Aaron Pickett(Executive Officer)Wing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)Jamil Beg(Director)
HealthtechCalabasas, US
Michael Balmuth(Became Director as of July 8, 2016)Nitin Nanda, M.D.(Executive Officer, Director)John Eugene Hill(Became Director as of July 8, 2016)Deepak Chopra(Director)Vikram Marla(Resigned as director July 8, 2016)John Tadich(Became Director as of July 8, 2016)
Clinical-stage company developing novel treatment for recurrent high-grade gliomas
HealthtechChanhassen, US
Jeremy Ling(Executive Officer)Steve Weiner(Executive Officer)Vijay Agarwal(Executive Officer, Director)William Davis(Executive Officer, Director)
BoardKlaus Veitinger(Director)Imran Eba(Executive Officer)
BiotechLebanon, US
Kevin Isett(Executive Officer, Director)Claudio Nessi(Director)Warren Kett(Executive Officer)Jon Sheller(Executive Officer)Michael Ross(Director)Philip Ferneau(Director)
BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity.
Digital HealthHealthtechMedical DevicesSeattle, US
Mark Querry(Executive Officer)Kevin Nelson, III(Executive Officer)Rik Vandevenne(Director)Gust H. Bardy(Executive Officer, Director, Promoter)Alan Levy(Director)Mark Handfelt(Executive Officer, Promoter)
Injectable Neural Iceβ’ for pain relief in osteoarthritis and hip pain
A pharmaceutical company that develops medicines and vaccines, with research, clinical trials, and a drug pipeline.
BiotechHealthtech
Scottsdale, US
Michelle Miller(Executive Officer)Adam T. Miller(Executive Officer, Director)James J. Quagliaroli(Member of the Management Board of Issuer)Michael McNelis(Executive Officer)Glenn M. Parker(Executive Officer, Director)
Cerevance is a clinical-stage drug discovery and development company developing non-dopaminergic, orally-delivered therapies for brain and central nervous system disorders, including Parkinson's disease, schizophrenia, Alzheimer's disease, and ALS.
BiotechDeep TechHealthtech
Craig Thompson(Chief Executive Officer)Sagar Vaidya(Chief Medical Officer)Carrie Ann Cook(Chief Business Officer)
Nuwellis is a commercial-stage medical device company that makes the Aquadex SmartFlow ultrafiltration system for cardiorenal fluid management.
HardwareHealthtechMedical Devices
PartnerCharles DunnΒ· led
BiotechCambridge, US
Noubar B. Afeyan, Ph.D.(Director)Jennifer Glennon(Executive Officer)Balkrishan (Simba) Gill, Ph.D.(Executive Officer, Director)David R. Epstein(Director)Lord Ara Darzi(Director)Duncan McHale(Executive Officer)
Evidation collects and analyzes real-world health data from millions of community members to enable clinical research and health programs across various medical conditions.
BiotechData & InfrastructureDigital HealthHealthtechSan Francisco, US
David Fleshman(Director)Rowan Chapman(Director)Christine Lemke(Executive Officer, Director)Deborah Kilpatrick(Executive Officer, Director)
Fort Worth, US
Stephen Griggs(Director)Liston Thomas(Director)Stacie Bratcher(Executive Officer)David Tamburri(Director)Jim Douthitt(Mr. Douthitt is the Secretary of the Issuer.)James Glynn(Director)
HealthtechWestborough, US
Chris Joyce(Executive Officer)Patrick McBrayer(Executive Officer, Director)Sean Sansiveri(Director)Pieter Wolters(Director)
BoardMarc-Andre Marcotte(Director)Joyce Erony(Director)
BiotechHealthtechIndianapolis, US
Richard Dodson(Executive Officer, Director)James Floyd(Executive Officer, Director)Anders Weaver(Executive Officer, Director)Phillip Clem(Executive Officer, Director)
Harnesses cutting-edge technologies to design exquisitely selective small molecule therapeutics.
BiotechJackson, US
Zach Hall(Director)Ephraim Heller(Director)William McDowell(Director)Irene Griswold-Prenner(Executive Officer, Director)Regis Kelly(Director)
Onkos Surgical develops orthopaedic implants and an FDA-granted antibacterial coating technology intended to protect implants from bacteria at the time of surgery.
HealthtechMedical DevicesParsippany, US
BiotechNew York, US
David Redlick(Director)Michael Ross(Director)Keith Westby(Executive Officer)David Carroll(Executive Officer)Thomas Dyrberg(Director)Glenn Sblendorio(Executive Officer, Director)
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)Liam Mullins(CTO and Co-founder)
Podimetrics develops a remote monitoring solution combining the SmartMat device and personalized support to identify high-risk individuals with complex diabetes and enable early intervention to prevent complications.
Digital HealthHealthtechMedical DevicesSomerville, US
David Linders(Executive Officer, Director)Jonathan Bloom(Executive Officer, Director)
BoardAaron Sandoski(Director)
Clinical stage company transforming lives in immune mediated disease
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)Roet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)Shafique Virani(Executive Officer)Jason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)
Schweiger operates dermatology and allergy clinics offering in-person and virtual care for skin conditions such as acne, eczema, psoriasis, and contact dermatitis, plus allergy testing, immunotherapy, and hives treatment.
Digital HealthHealthtechWellness & Fitness
Spineology develops OptiMesh, a conformable mesh interbody fusion device that is placed in the disc space through a small portal and filled with bone graft in-situ to restore disc height, achieve spinal alignment, and promote fusion.
BiotechHealthtechMedical DevicesSt. Paul, US
JAMISON YOUNG(Executive Officer)BRIAN SNIDER(Executive Officer, Director)Donald R. Brattain(Director)Edson W. Spencer(Director)John J. Booth(Executive Officer, Director)James T. Rybicki(Director)
Menlo Park, US
Jim Bristol(Director)Daniel Estes(Director)Scott Byrd(Executive Officer, Director)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.